Markt für Transplantationsdiagnostik – Erkenntnisse aus globaler und regionaler Analyse – Prognose bis 2031

  • Report Code : TIPRE00003076
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 150
Buy Now

Die Größe des Marktes für Transplantationsdiagnostik wird bis 2027 auf 1.542,89 Millionen US-Dollar geschätzt, gegenüber 789,88 Millionen US-Dollar im Jahr 2018; Es wird geschätzt, dass sie zwischen 2019 und 2027 mit einer jährlichen Wachstumsrate von 7,9 % wächst.



Transplantationsdiagnostik bezieht sich auf diagnostische Tests, die an den Organen durchgeführt werden, die transplantiert werden sollen. Diese Tests werden entweder vor oder nach der Transplantation durchgeführt. Zu den in der Transplantationsdiagnostik gebräuchlichen Techniken gehören sequenzbasierte molekulare Tests, PCR-basierte molekulare Tests und in bestimmten Fällen nichtmolekulare Tests. Die Transplantationsdiagnostik ist ein wesentlicher Faktor bei der Organtransplantation, da sie weitere Komplikationen vermeidet, die nach einer Transplantation auftreten könnten.





Das Wachstum des Marktes für Transplantationsdiagnostik wird auf die steigende Prävalenz von Herz-Kreislauf-Erkrankungen zurückgeführt Krankheiten und ein signifikantes Wachstum der Biotechnologieindustrie. Teure Organtransplantationen können jedoch das Marktwachstum behindern.



Lukrative Regionen für den Markt für Transplantationsdiagnostik



Markteinblicke



Steigende Prävalenz von Herz-Kreislauf-Erkrankungen

CVDs sind weltweit die häufigste Todesursache. Die alternde Bevölkerung zeigt im Laufe ihres Lebens häufig strukturelle und funktionelle Veränderungen der Gefäßansammlung. Dadurch erhöht sich das Risiko, an Herz-Kreislauf-Erkrankungen zu erkranken. Nach Angaben des American College of Cardiology sind Herz-Kreislauf-Erkrankungen für fast 800.000 Todesfälle in den USA verantwortlich, was etwa jedem dritten Todesfall entspricht. Die koronare Herzkrankheit (KHK) ist für die Mehrzahl der Todesfälle durch Herz-Kreislauf-Erkrankungen verantwortlich, gefolgt von Schlaganfall und Herzversagen. Bei fast über 90 Millionen Amerikanern wird Herz-Kreislauf-Erkrankungen diagnostiziert. Darüber hinaus wird angegeben, dass Herz-Kreislauf-Erkrankungen weltweit etwa 31 % aller Todesfälle ausmachen und dass die Kosten für Herz-Kreislauf-Erkrankungen bis 2030 voraussichtlich etwa 1.044 Milliarden US-Dollar betragen werden.



Die CVD-Ergebnisse für 45,0 % aller Todesfälle in Europa und 37,0 % aller Todesfälle in der EU. Aus diesem Grund dürfte der Bedarf an Transplantationsdiagnostik für Organtransplantationen den Markt im Prognosezeitraum antreiben.



Produkt- und dienstleistungsbasierte Einblicke



Der globale Markt für Transplantationsdiagnostik, basierend auf auf Produkte und Dienstleistungen, ist in Instrumente, Reagenzien und Verbrauchsmaterialien sowie Software und Dienstleistungen unterteilt. Das Segment Reagenzien und Verbrauchsmaterialien war 2018 das größte Segment unter den Produkt- und Dienstleistungsuntersegmenten im Markt für Transplantationsdiagnostik. Es wird jedoch erwartet, dass das Segment Software und Dienstleistungen im Zeitraum 2019–2027 ein Nachfragewachstum mit der höchsten jährlichen Wachstumsrate von 9,6 % verzeichnen wird.



Typbasierte Erkenntnisse



Der globale Markt für Transplantationsdiagnostik ist je nach Typ in Organtransplantation, Weichteiltransplantation und Stammzelltransplantation unterteilt. Das Segment der Organtransplantation hielt 2018 den größten Anteil am Markt für Transplantationsdiagnostik und wird voraussichtlich auch im Prognosezeitraum weiterhin den größten Markt halten.



Technologiebasierte Erkenntnisse



The Der globale Markt für Transplantationsdiagnostik ist technologiebasiert in molekulare und nichtmolekulare Tests unterteilt. Im Jahr 2018 hielt das Segment der molekularen Assaysysteme einen größeren Marktanteil und es wird erwartet, dass die Nachfrage im Zeitraum 2019–2027 mit einer schnelleren jährlichen Wachstumsrate von 9,5 % wächst.



Anwendungsbasierte Erkenntnisse

Der globale Markt für Transplantationsdiagnostik ist je nach Anwendung in diagnostische Anwendungen und Forschungsanwendungen unterteilt. Im Jahr 2018 hielt das Segment der Diagnoseanwendungen einen größeren Marktanteil und wird in den kommenden Jahren voraussichtlich schneller wachsen.



Strategische Erkenntnisse



Produkteinführungen und -zulassungen sind häufig Von Unternehmen übernommene Strategien zur Erweiterung ihrer globalen Präsenz und ihres Produktportfolios. Darüber hinaus konzentrieren sich die Marktteilnehmer der Transplantationsdiagnostik auf die Partnerschaftsstrategie, um ihren Kundenkreis zu vergrößern, was ihnen wiederum ermöglicht, ihren Markennamen auf der ganzen Welt zu behaupten.



Unternehmensprofile



    < li>BIO-RAD LABORATORIES, INC
  • BIOMÉRIEUX SA

  • ILLUMINA, INC.

  • THERMO FISHER SCIENTIFIC, INC.

  • QIAGEN NV

  • F. HOFFMANN-LA ROCHE LTD.

  • HOLOGIC INC.

  • LUMINEX CORPORATION

  • OMIXON INC.

  • ABBOTT

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are transplant diagnostics?

Transplant diagnostics refers to the diagnostics tests that are conducted on the organs that are meant to be transplanted. These tests are performed pre and post transplantation.

What are major common techniques used in transplant diagnostics?

Some of the common techniques used in transplant diagnostics include, sequence based molecular assays, and PCR based molecular assays and also non-molecular assays in certain cases.

Who are the key players in the transplant diagnostics market?

The major key players are Abbott, Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, Omixon Inc., Hologic Inc., Luminex Corporation, F. Hoffmann-La Roche Ltd, bioMérieux SA.

The List of Companies
  1. Thermo Fisher Scientific Inc.
  2. Abbott
  3. Illumina, Inc.
  4. F. Hoffmann-La Roche Ltd
  5. Bio-Rad Laboratories, Inc.
  6. bioMérieux SA
  7. QIAGEN
  8. Hologic Inc.
  9. Luminex Corporation
  10. Omixon Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports